Skip to content
SFB-Pharma

SFB-Pharma

  • Office
  • Contact
  • About Us
Posted on 7 January 20207 January 2020 by Christine Laroche

Bienvenue dans – Welkom bij:

Bienvenidos en – Welcome to:

SFB-Pharma

If you want to reach me please send a message to:

Christine Laroche  claroche@sfb-pharma.com

Recent Posts

  • (no title)

Archives

  • January 2020

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

RSS Drugs.com – New Drug Approvals

  • FDA Approves Qwo (collagenase clostridium histolyticum-aaes) as the First Injectable Treatment for Cellulite
  • FDA Approves Rukobia (fostemsavir) for HIV in Adults with Few Treatment Options Available
  • FDA Approves Byfavo (remimazolam injection) for the Induction and Maintenance of Procedural Sedation
  • FDA Approves Dojolvi (triheptanoin) for the Treatment of Long-Chain Fatty Acid Oxidation Disorders

RSS Pharma Manufacturing News

  • EMA grants accelerated assessment for trastuzumab deruxtecan in metastatic breast cancer
  • Idorsia announces positive results in second phase 3 study of daridorexant
  • Ascentage, MSD to study APG-115, KEYTRUDA combo in advanced solid tumours

SFB-Pharma Info

  • About Us
  • Contact
  • Office

RSS White papers and Web seminars

  • Cloud Transformations: A Provider’s Guide
  • AI-Enabled Clinical Virtual Assistant – A HIMSS Technology Update
  • Situational Response Management, Communications, and Virtual Patient Outreach
  • Digitize Clinical Workflows to Create an Integrated Care Platform
Proudly powered by WordPress
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok